An update on raloxifene.
Draper
M W
MW
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
D001943:Breast Neoplasms / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D016889:Endometrial Neoplasms / Q000517:prevention & control*; D005260:Female; D006801:Humans; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*
D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride